J clin oncol 2013 31:845-852
WebJan 1, 2003 · Purpose: The Head and Neck Intergroup conducted a phase III randomized trial to test the benefit of adding chemotherapy to radiation in patients with unresectable … WebApr 4, 2024 · J Clin Oncol. 2013;31:845-852. 5. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of …
J clin oncol 2013 31:845-852
Did you know?
http://www.zlfzyj.com/CN/abstract/abstract10225.shtml Web J Clin Oncol. 2013;31(7):845-852. doi:10.1200/JCO.2012.43.6097 PubMed Google Scholar Crossref 25. Tester W, Caplan R, Heaney J, et al. Neoadjuvant combined …
WebJul 13, 2024 · Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis Pediatric Cancer JAMA Oncology JAMA Network This meta-analysis examines the association of minimal residual disease status with acute lymphoblastic leukemia in children and adults. [Skip to … WebJul 28, 2024 · The main objective was evaluation of the feasibility of the study procedures. To determine feasibility, we evaluated (serious) adverse events, the rate of toxicity (according to National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0), recruitment rate, and the percentage of patients completing the protocol.
WebNov 9, 2024 · Summary of Evidence. Background. In 2024, over 160,000 men in the United States (U.S.) were diagnosed with prostate cancer, which accounted for 9.6% of all new cancer diagnoses. 1 Clinically localized prostate cancer accounts for ~80% of newly diagnosed cases. 1 The NCCN, classifies these men into risk groups based on clinical and … WebIbero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin
WebCancer Research on Prevention and Treatment 2024, Vol. 50 Issue (04): 327-333 DOI: 10.3971/j.issn.1000-8578.2024.22.1296 Progress on Multi-disciplinary Combined Therapy for Locally Advanced Hypopharyngeal Carcinoma. LUO Xi, YI Junlin: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer ...
WebOncologists also saw a patient profile for each choice. This profile included seven attributes: patient age (under or over 65 years), ECOG status (0–1, 2, or 3), comorbid conditions … creative imedia level 2 passWebJan 20, 2024 · Pancreatic cancer (PC) is difficult to detect in the early stages; thus, identifying specific and sensitive biomarkers for PC diagnosis is crucial, especially in the … maldive bassa stagioneWebDec 26, 2024 · Forastiere AA, et al. N Engl J Med 2003;349:2091-2098 RTOG 9111: Larynx Preservation Trial The median follow-up among surviving patients, 3.8 years Demographics: median age 59 years; 94% KPS 80; 50% N0; 68% SGL; 28% N2-3 27. P<0.001 Forastiere AA, et al. J Clin Oncol 2013;31:845-852. creative imedia gradesWebJan 11, 2024 · A total of 11 patients, 6 from the SAbR arm and 5 from the maintenance chemotherapy–alone arm, had brain metastases treated prior to enrollment (eTable 1 in … maldive che ore sonoWebIntroduction. Sinonasal mucosal melanoma (SNMM) is a rare tumor, comprising about 1% of all melanomas and about 4–8% of sinonasal malignancies. 1,2 In recent years, SNMM has been considered and managed as a separate disease from cutaneous melanoma, including its staging system and treatment modalities. 3 SNMM most commonly affects the nasal … creative imedia past paperWebPurpose To report the long-term results of the Intergroup Radiation Therapy Oncology Group 91-11 study evaluating the contribution of chemotherapy added to radiation therapy (RT) for larynx preservation. maldive chinaWebJan 11, 2024 · Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial. Lung Cancer. 2006;52(2):155-163. PubMedGoogle ScholarCrossref 5. Paz-Ares LG, de Marinis F, Dediu M, J Clin Oncol. 2013;31(23):2895-2902. creative imedia past paper 2021